AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes
AUAUniversity5 Jul 2023

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas Urovant Sciences, Inc.

Episoder(423)

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

2018 AUA Annual Meeting Presidential Address J. Brantley Thrasher, MD, FACS Department of Urology, University of Kansas Health System

21 Jan 202019min

AUA2017 Presidential Address: Urology: A Personal Perspective

AUA2017 Presidential Address: Urology: A Personal Perspective

2017 AUA Annual Meeting Presidential Address Urology: A Personal Perspective Richard K. Babayan, MD, FACS

14 Jan 202023min

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

2016 AUA Annual Meeting Presidential Address William F. Gee, MD Lexington, KY

8 Jan 202020min

Targeted Therapies In Renal Cell Carcinoma

Targeted Therapies In Renal Cell Carcinoma

Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of...

24 Des 201933min

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual p...

18 Des 201937min

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological age...

11 Des 201927min

Adjuvant Therapy in Renal Cell Carcinoma

Adjuvant Therapy in Renal Cell Carcinoma

Co-Host: Alexander Kutikov, MD, FACS At the conclusion of these activities, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of RCC. 2. Identify b...

4 Des 201932min

Comorbidities in Advanced Prostate Cancer

Comorbidities in Advanced Prostate Cancer

Co-Host: Alicia K. Morgans, MD, MPH At the conclusion of these activities, participants will be able to: 1. Recognize cardiovascular comorbidities and describe their management in the context of pros...

27 Nov 201928min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
rss-strid-de-norske-borgerkrigene
foreldreradet
jakt-og-fiskepodden
rss-sunn-okonomi
merry-quizmas
hverdagspsyken
gravid-uke-for-uke
sinnsyn
rss-mann-i-krise-med-sagen
rss-impressions-2
rss-kunsten-a-leve
hagespiren-podcast
fryktlos
babyverden
level-up-med-anniken-binz
nevropodden